Adult Immunizations

  1. Pierce Gardner, MD;
  2. Theodore Eickhoff, MD;
  3. Gregory A. Poland, MD;
  4. Peter Gross, MD;
  5. Marie Griffin, MD;
  6. F. Marc LaForce, MD;
  7. William Schaffner, MD; and
  8. Raymond Strikas, MD
  1. From the State University of New York at Stony Brook, Stony Brook, New York; University of Colorado Health Sciences Center, Denver, Colorado; Mayo Clinic and Foundation, Rochester, Minnesota; Hackensack Medical Center, Hackensack, New Jersey; Vanderbilt University School of Medicine, Nashville, Tennessee; University of Rochester School of Medicine and Dentistry, Rochester, New York; and the Centers for Disease Control and Prevention, Atlanta, Georgia. Acknowledgments: The authors thank Linda Johnson White and Bobbie Lewis, of the American College of Physicians, for their assistance. Requests for Reprints: Pierce Gardner, MD, Associate Dean for Academic Affairs, School of Medicine, State University of New York at Stony Brook Health Sciences Center, Stony Brook, NY 11794-8432. Current Author Addresses: Dr. Gardner: School of Medicine, State University of New York at Stony Brook Health Sciences Center, Stony Brook, NY 11794-8432.

    Abstract

    New vaccines have been licensed for hepatitis A, varicella, and typhoid.This paper reviews these vaccines and their recommended uses in adults. Special attention is given to a new national policy establishing age 50 years as a time for review of preventive health measures with emphasis on evaluating risk factors that indicate a need for pneumococcal vaccine and the initiation of annual influenza immunization.

    « Previous | Next Article »Table of Contents